Chestnut Hill, MA, United States of America

Omid C Farokhzad

USPTO Granted Patents = 73 (Patent Applications = 44)

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 26)

Average Co-Inventor Count = 5.1

ph-index = 21

Forward Citations = 1,194(Granted Patents)

Forward Citations (Not Self Cited) = 1,008(Dec 10, 2025)

Location History:

Boston, MA (US) (2009 - 2010)
Chestnut Hill, MA (US) (2012 - 2020)
Waban, MA (US) (2014 - 2024)

Company Filing History:

63 out of 1,373

The Brigham and Women's Hospital, Inc.

patents

48 out of 8,373

Massachusetts Institute of Technology

Children's Medical Center Corporation

The Brigham and Women's Hosptial, Inc.

Icahn School of Medicine at Mount Sinai

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Protein Corona Analysis

Nanoparticle Drug Delivery

Vaccine Nanotechnology

Cationic Nanoparticles

Controlled Release Gels

Therapeutic Targets

Biofluid Sample Processing

Microfluidic Synthesis

Tumor Suppression Restoration

Targeted Delivery Systems

Functionalized Particles

Biodegradable Polymers

73 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12360109 - System and sensor array (2025-07-15),

2. 12287331 - Compositions, methods and systems for protein corona analysis and uses thereof (2025-04-29),

3. 12285464 - Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (NASH) (2025-04-29),

4. 12276668 - Compositions and methods for assaying proteins and nucleic acids (2025-04-14),

5. 12228566 - System and method for protein corona sensor array for early detection of diseases (2025-02-18),

6. 12222349 - Compositions, methods and systems for protein corona analysis and uses thereof (2025-02-11),

7. 12087405 - Methods of processing a biofluid sample (2024-09-10),

8. 12055541 - System and sensor array (2024-08-06),

9. 12000827 - System and method for protein corona sensor array for early detection of diseases (2024-06-04),

10. 11850309 - Cationic materials and formulations for drug delivery (2023-12-26),

11. 11833255 - Nanoparticles with pH triggered drug release (2023-12-05),

12. 11672864 - Nanostructured gels capable of controlled release of encapsulated agents (2023-06-13),

13. 11664092 - Lung biomarkers and methods of use thereof (2023-05-30),

14. 11567086 - System and method for protein corona sensor array for early detection of diseases (2023-01-31),

15. 11547667 - Vaccine nanotechnology (2023-01-10),

Title: The Innovative Mind of Omid C. Farokhzad

Introduction: Omid C. Farokhzad, a renowned male inventor hailing from Chestnut Hill, MA (US), is a prominent figure in the field of innovations and inventions, particularly in the realm of healthcare and nanomedicine.

Latest Patents: Omid C. Farokhzad holds several groundbreaking patents in the field of nanomedicine, focusing on targeted drug delivery systems and personalized medicine. His recent patents showcase his commitment to revolutionizing the way we approach healthcare treatments.

Career Highlights: With a distinguished career spanning decades, Omid C. Farokhzad has made significant contributions to the field of nanomedicine. His work has not only garnered international recognition but has also paved the way for advancements in personalized medicine, ultimately improving patient outcomes.

Collaborations: Throughout his career, Omid C. Farokhzad has collaborated with leading researchers, scientists, and healthcare professionals to further his research in nanomedicine. His collaborative efforts have resulted in groundbreaking discoveries and innovative solutions that have the potential to shape the future of healthcare.

Conclusion: Omid C. Farokhzad's dedication to innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the field of nanomedicine. His contributions continue to inspire the next generation of inventors and researchers to push the boundaries of what is possible in the world of healthcare and beyond.

This text is generated by artificial intelligence and may not be accurate.